Gregory V. Carr

National Institute of Mental Health, Bethesda, MD, United States 
mood disorders, behavioral pharmacology, schizophrenia
"Gregory Carr"
Mean distance: 14.65 (cluster 19)


Sign in to add mentor
Irwin Lucki grad student 2006-2009 Penn
 (Antidepressant and anxiolytic-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.)
Francesco Papaleo post-doc NIMH, NIH, Betehsda, MD
Daniel R. Weinberger post-doc 2010- NIMH
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

DeBrosse AC, Wheeler AM, Barrow JC, et al. (2020) Inhibition of Catechol--methyltransferase Does Not Alter Effort-Related Choice Behavior in a Fixed Ratio/Concurrent Chow Task in Male Mice. Frontiers in Behavioral Neuroscience. 14: 73
Byers S, Buchler IP, DePasquale M, et al. (2020) Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility. Psychopharmacology
Hallock H, Valerino J, DeBrosse A, et al. (2020) Involvement of a Locus Coeruleus-to-Prefrontal (LC-mPFC) Circuit in a Touchscreen Variant of the Continuous Performance Test (CPT) in Mice Biological Psychiatry. 87: S190
Lohoff FW, Carr GV, Brookshire B, et al. (2019) Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling. Brain Research
Carr GV, Maltese F, Sibley DR, et al. (2017) The Dopamine D5 Receptor Is Involved in Working Memory. Frontiers in Pharmacology. 8: 666
Papaleo F, Yang F, Paterson C, et al. (2016) Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 4859-75
Detrait ER, Carr GV, Weinberger DR, et al. (2016) Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice. Behavioural Pharmacology
Carr GV, Chen J, Yang F, et al. (2016) KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia. Molecular Psychiatry
Carr GV, Jenkins KA, Weinberger DR, et al. (2013) Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior. Behavioural Brain Research. 241: 173-84
Carr GV, Lucki I. (2011) The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology. 213: 265-87
See more...